AV nodal ablation in atrial fibrillation: long term outcomes

Abstract

Abstract Background Ablation of the atrioventricular (AV) node, following the insertion of a permanent pacemaker, is a treatment option for symptomatic atrial fibrillation (AF) where rate control is poor, despite maximally tolerated pharmacological intervention or percutaneous AF ablation [1], and yet there is limited data on long-term outcomes. Purpose The purpose of this study is to investigate post AV node ablation follow up outcomes, including the incidence and timeframe of conversion of paroxysmal to persistent AF; incidence and timeframe of upgrade to biventricular pacemakers; and mortality. Methods This observational descriptive study looked at the post-procedure follow-up outcomes of patients who underwent AV node ablation at our centre between March 2015 and June 2019. Retrospective analysis of prospectively collected data was analysed. The demographics of the patients, including their age, gender, co-morbidities, pre-ablation left ventricular ejection fraction (LVEF) and medications were recorded. The follow up outcomes investigated included the change in LVEF, the proportion of patients whose AF converted from paroxysmal to persistent, the proportion of patients requiring upgrade to biventricular devices, and deaths within 6 months of ablation. Outcomes were compared between those who had a biventricular pacemaker pre-ablation and those who had single/dual chamber pacemakers. Results 296 patients with a mean age of 72.7± 8.5 years and a female to male ratio of 54.1% : 45.9% were included. 94 patients (31.8%) had paroxysmal AF pre- ablation. 51.6% of those who had paroxysmal AF pre-ablation converted to persistent AF over a median period of 3 years (interquartile range, 3 years). Among those who had a biventricular pacemaker pre-ablation, 56.5% of those with paroxysmal AF converted to persistent, compared to 47.4% of those with a dual pacemaker pre-ablation p=ns Among patients with dual chamber pacemakers, those who remained in paroxysmal AF post-ablation had a mean CHADVASC score of 3.2 (range of 1-6) compared to 3.7 (range of 2-6) in those whose AF converted to persistent (p=0.19). 9 patients (3%) died within less than 6 months of the procedure, with 1 patient dying within 6 days. 13% of the patients originally having a single or dual chamber pacemaker required an upgrade to a biventricular pacemaker over a median period of 1.25 years (interquartile range 1.1 years). All the patients who required an upgrade to a biventricular pacemaker had normal LVEF pre-ablation except for one patient who had mild LV impairment. Conclusions A significant proportion of patients with paroxysmal AF converted to persistent AF following AV node ablation and having a biventricular pacemaker did not offer benefit in keeping people in paroxysmal AF.A considerable number of people required an upgrade to biventricular pacemaker over a short time frame even though they had normal LVEF pre AV nodal ablation.